Epigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writers

被引:13
作者
Farooqi, Ammad Ahmad [1 ]
Tang, Jen-Yang [2 ,3 ,4 ]
Li, Ruei-Nian [5 ]
Ismail, Muhammad [1 ]
Chang, Yung-Ting [6 ]
Shu, Chih-Wen [7 ]
Yuan, Shyng-Shiou F. [8 ,9 ]
Liu, Jing-Ru [5 ]
Mansoor, Qaisar [1 ]
Huang, Chih-Jen [2 ,3 ]
Chang, Hsueh-Wei [5 ,9 ,10 ,11 ]
机构
[1] KRL Hosp, IBGE, Islamabad, Pakistan
[2] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Radiat Oncol, Kaohsiung 80708, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Kaohsiung 80708, Taiwan
[4] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Radiat Oncol, Kaohsiung 80708, Taiwan
[5] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 80708, Taiwan
[6] Natl Sun Yat Sen Univ, Acad Sinica, Doctor Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan
[7] Kaohsiung Med Univ, Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 80708, Taiwan
[8] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 80708, Taiwan
[9] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung 80708, Taiwan
[10] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 80424, Taiwan
[11] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung 80708, Taiwan
关键词
epigenetic; modification; methylation; natural products; cancer; WNT/BETA-CATENIN PATHWAY; DNA METHYLATION; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; OVARIAN-CANCER; BREAST-CANCER; CELL-GROWTH; NASOPHARYNGEAL CARCINOMA; MESENCHYMAL TRANSITION; RASSF1A EXPRESSION;
D O I
10.2147/IJN.S82527
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Research concerning the epigenome over the years has systematically and sequentially shown substantial development and we have moved from global inhibition of modifications of the epigenome toward identification and targeted therapy against tumor-specific epigenetic mechanisms. In accordance with this approach, several drugs with epigenetically modulating activity have received considerable attention and appreciation, and recently emerging scientific evidence is uncovering details of their mode of action. High-throughput technologies have considerably improved our existing understanding of tumor suppressors, oncogenes, and signaling pathways that are key drivers of cancer. In this review, we summarize the general epigenetic mechanisms in cancer, including: the post-translational modification of DNA methyltransferase and its mediated inactivation of Ras association domain family 1 isoform A, Sonic hedgehog signaling, Wnt signaling, Notch signaling, transforming growth factor signaling, and natural products with epigenetic modification ability. Moreover, we introduce the importance of nano-medicine for delivery of natural products with modulating ability to epigenetic machinery in cancer cells. Such in-depth and comprehensive knowledge regarding epigenetic dysregulation will be helpful in the upcoming era of molecular genomic pathology for both detection and treatment of cancer. Epigenetic information will also be helpful when nanotherapy is used for epigenetic modification.
引用
收藏
页码:3183 / 3191
页数:9
相关论文
共 84 条
[1]   Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells [J].
Agarwal, Soumik ;
Amin, Karishma S. ;
Jagadeesh, Shankar ;
Baishay, Gokul ;
Rao, Paruchuri G. ;
Barua, Nabin C. ;
Bhattacharya, Samir ;
Banerjee, Partha P. .
MOLECULAR CANCER, 2013, 12
[2]   WNT signalling pathways as therapeutic targets in cancer [J].
Anastas, Jamie N. ;
Moon, Randall T. .
NATURE REVIEWS CANCER, 2013, 13 (01) :11-26
[3]   Plant Polyphenols and Oxidative Metabolites of the Herbal Alkenylbenzene Methyleugenol Suppress Histone Deacetylase Activity in Human Colon Carcinoma Cells [J].
Anna Maria Groh, Isabel ;
Chen, Chen ;
Lueske, Claudia ;
Cartus, Alexander Thomas ;
Esselen, Melanie .
JOURNAL OF NUTRITION AND METABOLISM, 2013, 2013
[4]  
[Anonymous], EVID BASED COMPLEMEN
[5]   Evidence that γ-Secretase-Mediated Notch Signaling Induces Neuronal Cell Death via the Nuclear Factor-κB-Bcl-2-Interacting Mediator of Cell Death Pathway in Ischemic Stroke [J].
Arumugam, Thiruma V. ;
Cheng, Yi-Lin ;
Choi, Yuri ;
Choi, Yun-Hyung ;
Yang, Sunghee ;
Yun, Young-Kwang ;
Park, Jong-Sung ;
Yang, Dong Kwon ;
Thundyil, John ;
Gelderblom, Mathias ;
Karamyan, Vardan T. ;
Tang, Sung-Chun ;
Chan, Sic L. ;
Magnus, Tim ;
Sobey, Christopher G. ;
Jo, Dong-Gyu .
MOLECULAR PHARMACOLOGY, 2011, 80 (01) :23-31
[6]   Multiple Sequence-Specific Factors Generate the Nucleosome-Depleted Region on CLN2 Promoter [J].
Bai, Lu ;
Ondracka, Andre ;
Cross, Frederick R. .
MOLECULAR CELL, 2011, 42 (04) :465-476
[7]   Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets [J].
Baud, Matthias G. J. ;
Leiser, Thomas ;
Haus, Patricia ;
Samlal, Sharon ;
Wong, Ai Ching ;
Wood, Robert J. ;
Petrucci, Vanessa ;
Gunaratnam, Mekala ;
Hughes, Siobhan M. ;
Buluwela, Lakjaya ;
Turlais, Fabrice ;
Neidle, Stephen ;
Meyer-Almes, Franz-Josef ;
White, Andrew J. P. ;
Fuchter, Matthew J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (04) :1731-1750
[8]   A decade of exploring the cancer epigenome - biological and translational implications [J].
Baylin, Stephen B. ;
Jones, Peter A. .
NATURE REVIEWS CANCER, 2011, 11 (10) :726-734
[9]   The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis [J].
Benedito, Rui ;
Roca, Cristina ;
Soerensen, Inga ;
Adams, Susanne ;
Gossler, Achim ;
Fruttiger, Marcus ;
Adams, Ralf H. .
CELL, 2009, 137 (06) :1124-1135
[10]   Field defects in progression to gastrointestinal tract cancers [J].
Bernstein, Carol ;
Bernstein, Harris ;
Payne, Claire M. ;
Dvorak, Katerina ;
Garewal, Harinder .
CANCER LETTERS, 2008, 260 (1-2) :1-10